New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor

Detalhes bibliográficos
Autor(a) principal: Schuelter-Trevisol,Fabiana
Data de Publicação: 2016
Outros Autores: Schmitt,Graciane Jacinta, Araújo,Jane Martins de, Souza,Liliane Braga de, Nazário,Juliana Gomes, Januário,Raquel Landuchi, Mello,Rogério Sobroza de, Trevisol,Daisson José
Tipo de documento: Relatório
Idioma: eng
Título da fonte: Revista da Sociedade Brasileira de Medicina Tropical
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000100130
Resumo: Abstract: New Delhi metallo-beta-lactamase-1 (NDM-1) is a bacterial enzyme that renders the bacteria resistant to a variety of beta-lactam antibiotics. A 20-year-old man was hospitalized several times for surgical treatment and complications caused by a right-sided vestibular schwannoma. Although the patient acquired several multidrug-resistant infections, this study focuses on the NDM-1-producing Acinetobacter spp. infection. As it was resistant to all antimicrobials tested, the medical team developed a 20-day regimen of 750mg/day metronidazole, 2,000,000IU/day polymyxin B, and 100mg/day tigecycline. The treatment was effective, and the patient recovered and was discharged from the hospital.
id SBMT-1_b2583be028542becdf2974b49430b7c8
oai_identifier_str oai:scielo:S0037-86822016000100130
network_acronym_str SBMT-1
network_name_str Revista da Sociedade Brasileira de Medicina Tropical
repository_id_str
spelling New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivorAcinetobacterbeta-lactam resistancemicrobial drug resistanceAbstract: New Delhi metallo-beta-lactamase-1 (NDM-1) is a bacterial enzyme that renders the bacteria resistant to a variety of beta-lactam antibiotics. A 20-year-old man was hospitalized several times for surgical treatment and complications caused by a right-sided vestibular schwannoma. Although the patient acquired several multidrug-resistant infections, this study focuses on the NDM-1-producing Acinetobacter spp. infection. As it was resistant to all antimicrobials tested, the medical team developed a 20-day regimen of 750mg/day metronidazole, 2,000,000IU/day polymyxin B, and 100mg/day tigecycline. The treatment was effective, and the patient recovered and was discharged from the hospital.Sociedade Brasileira de Medicina Tropical - SBMT2016-02-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000100130Revista da Sociedade Brasileira de Medicina Tropical v.49 n.1 2016reponame:Revista da Sociedade Brasileira de Medicina Tropicalinstname:Sociedade Brasileira de Medicina Tropical (SBMT)instacron:SBMT10.1590/0037-8682-0150-2015info:eu-repo/semantics/openAccessSchuelter-Trevisol,FabianaSchmitt,Graciane JacintaAraújo,Jane Martins deSouza,Liliane Braga deNazário,Juliana GomesJanuário,Raquel LanduchiMello,Rogério Sobroza deTrevisol,Daisson Joséeng2016-03-15T00:00:00Zoai:scielo:S0037-86822016000100130Revistahttps://www.sbmt.org.br/portal/revista/ONGhttps://old.scielo.br/oai/scielo-oai.php||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br1678-98490037-8682opendoar:2016-03-15T00:00Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)false
dc.title.none.fl_str_mv New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
title New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
spellingShingle New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
Schuelter-Trevisol,Fabiana
Acinetobacter
beta-lactam resistance
microbial drug resistance
title_short New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
title_full New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
title_fullStr New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
title_full_unstemmed New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
title_sort New Delhi metallo-beta-lactamase-1-producing Acinetobacter spp. infection: report of a survivor
author Schuelter-Trevisol,Fabiana
author_facet Schuelter-Trevisol,Fabiana
Schmitt,Graciane Jacinta
Araújo,Jane Martins de
Souza,Liliane Braga de
Nazário,Juliana Gomes
Januário,Raquel Landuchi
Mello,Rogério Sobroza de
Trevisol,Daisson José
author_role author
author2 Schmitt,Graciane Jacinta
Araújo,Jane Martins de
Souza,Liliane Braga de
Nazário,Juliana Gomes
Januário,Raquel Landuchi
Mello,Rogério Sobroza de
Trevisol,Daisson José
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Schuelter-Trevisol,Fabiana
Schmitt,Graciane Jacinta
Araújo,Jane Martins de
Souza,Liliane Braga de
Nazário,Juliana Gomes
Januário,Raquel Landuchi
Mello,Rogério Sobroza de
Trevisol,Daisson José
dc.subject.por.fl_str_mv Acinetobacter
beta-lactam resistance
microbial drug resistance
topic Acinetobacter
beta-lactam resistance
microbial drug resistance
description Abstract: New Delhi metallo-beta-lactamase-1 (NDM-1) is a bacterial enzyme that renders the bacteria resistant to a variety of beta-lactam antibiotics. A 20-year-old man was hospitalized several times for surgical treatment and complications caused by a right-sided vestibular schwannoma. Although the patient acquired several multidrug-resistant infections, this study focuses on the NDM-1-producing Acinetobacter spp. infection. As it was resistant to all antimicrobials tested, the medical team developed a 20-day regimen of 750mg/day metronidazole, 2,000,000IU/day polymyxin B, and 100mg/day tigecycline. The treatment was effective, and the patient recovered and was discharged from the hospital.
publishDate 2016
dc.date.none.fl_str_mv 2016-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000100130
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000100130
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0037-8682-0150-2015
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
publisher.none.fl_str_mv Sociedade Brasileira de Medicina Tropical - SBMT
dc.source.none.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical v.49 n.1 2016
reponame:Revista da Sociedade Brasileira de Medicina Tropical
instname:Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT
instname_str Sociedade Brasileira de Medicina Tropical (SBMT)
instacron_str SBMT
institution SBMT
reponame_str Revista da Sociedade Brasileira de Medicina Tropical
collection Revista da Sociedade Brasileira de Medicina Tropical
repository.name.fl_str_mv Revista da Sociedade Brasileira de Medicina Tropical - Sociedade Brasileira de Medicina Tropical (SBMT)
repository.mail.fl_str_mv ||dalmo@rsbmt.uftm.edu.br|| rsbmt@rsbmt.uftm.edu.br
_version_ 1752122160167518208

Registros relacionados